Your browser doesn't support javascript.
loading
Phase 2 Study of Lutetium 177-Labeled Anti-Carbonic Anhydrase IX Monoclonal Antibody Girentuximab in Patients with Advanced Renal Cell Carcinoma.
Muselaers, Constantijn H J; Boers-Sonderen, Marye J; van Oostenbrugge, Tim J; Boerman, Otto C; Desar, Ingrid M E; Stillebroer, Alexander B; Mulder, Sasja F; van Herpen, Carla M L; Langenhuijsen, Johan F; Oosterwijk, Egbert; Oyen, Wim J G; Mulders, Peter F A.
Afiliación
  • Muselaers CH; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands. Electronic address: stijn.muselaers@radboudumc.nl.
  • Boers-Sonderen MJ; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Oostenbrugge TJ; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Boerman OC; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Desar IM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Stillebroer AB; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mulder SF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • van Herpen CM; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Langenhuijsen JF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Oosterwijk E; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Oyen WJ; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Mulders PF; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.
Eur Urol ; 69(5): 767-70, 2016 05.
Article en En | MEDLINE | ID: mdl-26706103
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioisótopos / Carcinoma de Células Renales / Radioinmunoterapia / Antineoplásicos Inmunológicos / Neoplasias Renales / Lutecio / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2016 Tipo del documento: Article Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioisótopos / Carcinoma de Células Renales / Radioinmunoterapia / Antineoplásicos Inmunológicos / Neoplasias Renales / Lutecio / Anticuerpos Monoclonales Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur Urol Año: 2016 Tipo del documento: Article Pais de publicación: Suiza